Objective: To determine the frequency of potential drug-disease interaction in elderly patients in family practices. To assess which drugs and diagnoses are associated with a high risk related to drug-disease interaction and whether there are gender-or age-related differences. Methods: In routinely recorded electronic patient records, patients at least 65 years old with at least one diagnosis named in Beers list and one prescription were identified. Potential drug-disease interaction (PDDI) was presumed if within the same 3 months a "Beers" diagnosis and a potentially inappropriate prescription with respect to this diagnosis were documented for a patient. Multiple logistic regression analysis identified factors associated with a high risk of PDDI. Results: Of 24,619 patients (63.4% women) corresponding to our inclusion criteria, 10.4% were exposed to at least one PDDI. Almost no (0.0%) PDDI was associated with the most common Beers disorder hypertension (prevalence 49.2%). However, 23.4% of men suffering from bladder outflow obstruction (prevalence 17.6% in males) were exposed to at least one PDDI.
Introduction
At present, 16.8 million people in Germany, representing 20% of the total population, are older than 64 years [1] . Similarly, in the US, demographic projections suggest that the number of people ≥ 65 will increase to 72 million in 2030, corresponding to ~ 20% of the total U.S. population [2] . Primary care for the elderly is mainly provided by family practitioners (FPs). Elderly patients often exhibit an increased sensitivity to a large number of drugs [3] , particularly to medications targeting the central nervous system. At the same time, sensitivity of β-adrenergic cardiovascular receptors is reduced [3, 4] . Since over 50% of all patients aged 65 years or more take at least 5 drugs daily, plus an often unknown amount of over the counter medication, doctors need to be aware of potentially inappropriate medication (PIM) and potential drug-disease interaction (PDDI) in these patients [5, 6, 7] .
Since 1991, the Beers list has been used to evaluate and optimize drug therapy in elderly patients [8] . Updated in 1997, the list was revised by Fick et al. in 2003 [9, 10] . In 2007, the Beers list was adapted to the German pharmaceutical market [11] . Like its American predecessor, the first part of the German version contains a list of drugs that should generally better be avoided in patients older than 65 years, independent of diagnoses. The second part comprises potentially unsuitable drugs with regard to specific diagnoses. [21] . A systematic review on potentially inappropriate medication in European outpatients found a prevalence of 20.5% according to the Beers list [22] . All these studies, however, reflect on "general" PIM without regarding patients' specific disease context. Despite the growing interest in polypharmacotherapy and its risks, studies specifically featuring PDDI as presented in the second section of the Beers list (and somewhat less precisely but more illustratively also in the PRISCUS list) are still rare. The issue of PDDI was not included in Opondo's review [22] due to the methodological heterogeneity of publications. In the study of Lindblad et al. [23] , 15.3% of participating US veterans of at least 65 years were exposed to at least one instance of PDDI. In Ireland, 18.3% of communitydwelling elderly patients under FPs' care [24] and 34% of frail elderly patients admitted to a geriatric hospital unit for assessment as well as 32% admitted for acute illness had received PIM, and 17% of the former were exposed to PDDI [25, 26] . An 18% rate of PDDI was reported in nursing home patients in Japan [27] and the US [28] . A Dutch study concluded that elderly patients had a 20% chance of receiving at least one inappropriate drug (PIM or PDDI) within a 1-year period [29] . An American cohort study claimed that 27.6% of all adverse drug effects in elderly patients could have been avoided [30] . There is some evidence that PIM increase hospital admissions. Studies from England and Italy indicated that ~ 6% of all hospital admissions were due to adverse reactions caused by inappropriate medication [31, 32] . U.S. retirees taking one or more PIM were 1.8 to 1.9 times more likely to be hospitalized [33] . A Japanese study found a rate of 2.5 actual adverse drug events per 100 Beers list drugs taken by elderly patients admitted to hospitals [34] . However, according to a recent Cochrane review, adverse drug events, hospital admissions, and mortality could not be improved by interventions to optimize prescribing for nursing home residents [35] . The aim of this study was to investigate how common PDDI is among elderly patients (≥ 65 years) cared for by FPs in Germany, which drugs or diagnoses are associated with a high risk, and whether there are gender-or age-related differences.
Patients and methods

Study sample
Analysis was based on routine electronic patient records collected from a total of 148 FPs' practices between January 2000 and 2007 (the actual collection/observation period varied between practices, most data being available for the 2001 -2004 period due to participation in a larger research project [36]). All practice data sets were complete with regard to all patients seen in the practices during the respective observation periods. Records contained data on consultations, treatment, diagnoses (ICD-10 and plain text), medication, referrals, and on billing data [37] . The analysis included all records of patients who were aged 65 years or more at the time of the consultation, and, within the same 3-month time period, had a documented diagnosis of least one disorder named in the second, diagnosis-dependent part of the Beers list, and had received at least one drug prescription. Records of 24,619 patients fulfilling these criteria were available.
Preparation of data
Routinely recorded electronic patient records, exported via the treatment-datacarrier-("Behandlungsdatenträger" (BDT)) interface directly from the practice computers, were pseudonymized on site. BDT data files were assembled in a relational database, containing both plain text fields (medication, medical findings) and coded information (ICD-10 codes, drug product codes). Drugs were classified according to the ATC (anatomic-therapeutic-chemical) code, which was either decrypted from drug product codes (if these were present in the data), or else re-coded from drug trade names. For this, a Java program was developed that matched medication text records against a master data file provided by the German "Scientific Institute of the Statutory Health Insurance, WIdO") [38] . In a second step, all ICD-10-codes of disorders registered in the German adaption of the Beers list [11] were identified. In order to detect Beers disorders in the data, they were additionally identified by employing a thorough plain text search based on SPSS programming with explicit hand review for ambiguous cases. Finally, ATC-codes of drugs or drug classes named in the second part of the Beers list were identified. Relevant ATC-codes were assorted with regard to each "Beers disorder" by two FPs working independently. Cases of discrepancy were discussed; if necessary, an expert on pharmacology was consulted.
Data analysis
The units of analysis was cases of PDDI within patients, a case being defined as a patient for whom a disorder named in the Beers list and a prescription of a drug considered inappropriate with regard to this diagnosis were documented in the same quarter of a year period. Repeated prescriptions for the same patient, i.e., identical ATC-codes with respect to the same diagnosis in another quarter of a year period, were considered as a single case of PDDI. Instances of one single prescription being related to two different Beers diagnoses in the same patient were 
